Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center.

@article{Kalra2017EarlyTV,
  title={Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center.},
  author={Ankur Kalra and Hasan Rehman and Mahesh K. Ramchandani and Colin MacLeod Barker and Gerald M. Lawrie and Ross Michael Reul and Michael J. Reardon and Neil S. Kleiman},
  journal={The Journal of thoracic and cardiovascular surgery},
  year={2017},
  volume={154 4},
  pages={
          1235-1240
        }
}
BACKGROUND The Trifecta valve (St Jude Medical, Inc, St Paul, Minn) was approved for commercial use by the US Food and Drug Administration in 2011. Several isolated cases have been reported since then, describing early structural valve deterioration. We report a case series of 8 Trifecta valve failures, describing patients' clinical substrate and management, and the pathologic characteristics of the explanted valves. METHODS Trifecta valve failure occurred in 7 patients (8 valves) receiving… CONTINUE READING
BETA
3
Twitter Mentions

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve.

  • The Journal of thoracic and cardiovascular surgery
  • 2017
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…